Tempest Therapeutics Inc.
TPST | NASDAQ
$0.81
+$0.04 (+4.68%)
Sep 22, 2026, 11:30 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 22.18M | n/a | n/a | 67K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -22.18M | n/a | n/a | -67K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -5.25M | -27.72M | -4.08M | -3.6M | -7.97M | -10.94M | -13.92M | -10.55M | -9.58M | -7.97M | -7.51M | -6.59M | -7.47M | -7.58M | -8.93M | -8.77M | -8.77M | -8.16M | -7.34M | -7.74M | -6.79M | -5.13M |
Interest Income | 6K | n/a | 55K | 86K | 142K | 237K | 352K | 324K | 384K | 438K | 388K | 179K | 244K | 289K | 326K | 213K | 70K | 3K | n/a | 63K | 3K | 3K |
Pretax Income | -5.24M | -27.7M | -4.02M | -3.51M | -7.87M | -10.86M | -13.81M | -10.56M | -9.57M | -7.9M | -7.49M | -6.79M | -7.58M | -7.64M | -9.1M | -8.95M | -9.17M | -8.49M | -7.78M | -8.11M | -7.06M | -5.36M |
Net Income | -5.24M | -27.7M | -4.02M | -3.51M | -7.87M | -10.86M | -13.81M | -10.56M | -9.57M | -7.9M | -7.49M | -6.79M | -7.58M | -7.64M | -9.1M | -8.95M | -9.17M | -8.49M | -7.78M | -8.11M | -7.06M | -5.36M |
Selling & General & Admin | 3.43M | 5.43M | 3.54M | 3.03M | 4.1M | 3.31M | 3.18M | 2.99M | 3.75M | 3.63M | 3.33M | 2.37M | 3.05M | 2.9M | 3.14M | 2.8M | 3.12M | 3.05M | 2.62M | 3.11M | 2.56M | 1.54M |
Research & Development | 1.82M | 114K | 538K | 570K | 3.87M | 7.63M | 10.74M | 7.56M | 5.84M | 4.34M | 4.18M | 4.22M | 4.42M | 4.68M | 5.79M | 5.97M | 5.65M | 5.11M | 4.72M | 4.63M | 4.23M | 3.59M |
Other Expenses | n/a | n/a | n/a | n/a | -67K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 5.25M | 5.54M | 4.08M | 3.6M | 7.9M | 10.94M | 13.92M | 10.55M | 9.58M | 7.97M | 7.51M | 6.59M | 7.47M | 7.58M | 8.93M | 8.77M | 8.77M | 8.16M | 7.34M | 7.74M | 6.79M | 5.13M |
Interest Expense | n/a | 23K | n/a | n/a | 46K | 161K | 247K | 329K | 372K | 368K | 377K | 373K | 355K | 344K | 432K | 389K | 464K | 333K | 441K | 437K | 276K | 231K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.25M | 27.72M | 4.08M | 3.6M | 7.97M | 10.94M | 13.92M | 10.55M | 9.58M | 7.97M | 7.51M | 6.59M | 7.47M | 7.58M | 8.93M | 8.77M | 8.77M | 8.16M | 7.34M | 7.74M | 6.79M | 5.13M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 15.22M | 10.93M | 4.15M | 4.44M | 3.8M | 3.44M | 27.9M | 25.81M | 22.55M | 22.23M | 21.52M | 14.12M | 14.1M | 13.76M | 10.52M | 13.64M | 11.57M | 7.17M | 6.72M | 6.72M | 925.43K | 6.64M |
Shares Outstanding (Diluted) | 15.22M | 10.93M | 4.15M | 4.44M | 3.8M | 3.44M | 27.9M | 25.81M | 22.55M | 22.23M | 21.52M | 14.12M | 14.1M | 13.76M | 10.52M | 13.64M | 11.57M | 7.17M | 6.72M | 6.72M | 925.43K | 6.64M |
EPS (Basic) | -0.34 | -2.53 | -0.82 | -0.79 | -2.07 | -3.16 | -0.50 | -0.41 | -0.42 | -0.36 | -0.35 | -0.48 | -0.54 | -0.58 | -0.95 | -0.66 | -0.79 | -1.18 | -1.16 | -1.21 | -7.63 | -0.81 |
EPS (Diluted) | -0.34 | -2.53 | -0.82 | -0.79 | -2.07 | -3.16 | -0.50 | -0.41 | -0.42 | -0.36 | -0.35 | -0.48 | -0.54 | -0.58 | -0.95 | -0.66 | -0.79 | -1.18 | -1.16 | -1.21 | -7.63 | -0.81 |
EBITDA | -5.25M | -27.64M | -3.96M | -3.45M | -7.76M | -10.63M | -13.52M | -10.13M | -9.04M | -7.45M | -7.03M | -6.33M | -7.14M | -7.17M | -8.45M | -8.36M | -8.59M | -8.05M | -7.34M | -7.57M | -6.7M | -5.05M |
EBIT | -5.25M | -27.7M | -4.02M | -3.51M | -7.82M | -10.7M | -13.57M | -10.23M | -9.2M | -7.54M | -7.11M | -6.41M | -7.23M | -7.29M | -8.67M | -8.56M | -8.7M | -8.16M | -7.44M | -7.67M | -6.78M | -5.12M |
Depreciation & Amortization | n/a | 60K | 65K | 66K | 67K | 68K | 49K | 97K | 155K | 88K | 85K | 88K | 83K | 125K | 217K | 201K | 112K | 108K | 102K | 107K | 87K | 78K |
Add to Watchlist
Select watchlists to add or remove TPST